Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that's almost always caused by exposure to asbestos. Currently, the standard treatment is to remove the affected lung. "Current surgical and chemotherapy treatments of patients with malignant pleural mesothelioma are unsatisfactory and have not been shown to significantly prolong survival.

Full story: medicinenet.com